-
Mashup Score: 1Women in Interventional Cardiology: What are the Challenges and How to Overcome them? - 4 year(s) ago
Women in Interventional Cardiology: What are the Challenges and How to Overcome them?
Source: CardioTubeCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0FDA promises rigorous review of new renal denervation trials - 4 year(s) ago
As a new wave of renal denervation trials mature, the FDA is planning rigorous efficacy and safety monitoring.
Source: www.mdedge.comCategories: Cardiology News and JournalsTweet-
SPYRAL HTN OFF MED: Renal denervation is expected to heat up again if the results of the pivotal trial are positive. https://t.co/iw1Q9XfEDf #CRT2020 https://t.co/b8DmGcLplG
-
-
Mashup Score: 0
Patients with congestive HF and grade 2 to 4 functional mitral regurgitation despite medical therapy who underwent transcatheter mitral valve repair with the Carillon device had favorable survival rates at 5 years, according to a pooled analysis presented at a late-breaking science session at Cardiovascular Research Technologies. Findings from the trial have been simultaneously published in
Source: www.healio.comCategories: Cardiology News and JournalsTweet-
ICYMI: Patients with congestive HF and grade 2 to 4 functional mitral regurgitation despite medical therapy who underwent transcatheter mitral valve repair with the Carillon device had favorable survival rates at 5 years. #CRT2020 @Carillon_CDI https://t.co/PJ7qpW0N9C
-
-
Mashup Score: 0FDA promises rigorous review of new renal denervation trials - 4 year(s) ago
As a new wave of renal denervation trials mature, the FDA is planning rigorous efficacy and safety monitoring.
Source: www.mdedge.comCategories: General Medicine NewsTweet-
SPYRAL HTN OFF MED: Renal denervation is expected to heat up again if the results of the pivotal trial are positive. https://t.co/W2zeOip2QW #CRT2020 https://t.co/MGAkZu9z5T
-
-
Mashup Score: 0
Transcatheter aortic valve replacement was safe in low-risk patients with bicuspid aortic stenosis, as shown through short hospital stays, zero disabling stroke and zero deaths at 30 days, according to data from the Low-Risk TAVR trial presented at Cardiovascular Research Technologies. “Low-risk patients with symptomatic, severe bicuspid aortic stenosis are younger than patients with
Source: www.healio.comCategories: Cardiology News and JournalsTweet-
ICYMI: Transcatheter aortic valve replacement was safe in low-risk patients with bicuspid aortic stenosis, as shown through short hospital stays, zero disabling stroke and zero deaths at 30 days. @ron_waksman #CRT2020 @MedStarHeart https://t.co/qEoEiNKeWV
-
-
Mashup Score: 0
Patients with congestive HF and grade 2 to 4 functional mitral regurgitation despite medical therapy who underwent transcatheter mitral valve repair with the Carillon device had favorable survival rates at 5 years, according to a pooled analysis presented at a late-breaking science session at Cardiovascular Research Technologies. Findings from the trial have been simultaneously published in
Source: www.healio.comCategories: Cardiology News and JournalsTweet-
Patients with congestive HF and grade 2 to 4 functional mitral regurgitation despite medical therapy who underwent transcatheter mitral valve repair with the Carillon device had favorable survival rates at 5 years. #CRT2020 @Carillon_CDI #CardioTwitter https://t.co/PJ7qpVJci4
-
-
Mashup Score: 5
Low-risk patients who underwent transcatheter aortic valve replacement and took oral anticoagulation for 30 days had lower incidence of leaflet thrombosis without increased bleeding compared with those who took aspirin after the procedure, according to data from the Low-Risk TAVR trial presented at Cardiovascular Research Technologies. Another late-breaking trial session at this meeting
Source: www.healio.comCategories: Cardiology News and JournalsTweet-
ICYMI: “In low-risk patients, oral anticoagulation for 30 days after TAVR is associated with lower incidence of leaflet thrombosis but does not appear to be associated with increased bleeding,” - Toby Rogers, MD, PhD @MedStarHeart #CRT2020 https://t.co/ovqJEh6sJ6
-
-
Mashup Score: 0
Low-risk patients who underwent transcatheter aortic valve replacement and took oral anticoagulation for 30 days had lower incidence of leaflet thrombosis without increased bleeding compared with those who took aspirin after the procedure, according to data from the Low-Risk TAVR trial presented at Cardiovascular Research Technologies. Another late-breaking trial session at this meeting
Source: www.healio.comCategories: Cardiology News and JournalsTweet-
“In low-risk patients, oral anticoagulation for 30 days after TAVR is associated with lower incidence of leaflet thrombosis but does not appear to be associated with increased bleeding,” - Toby Rogers, MD, PhD @MedStarHeart #CRT2020 https://t.co/ovqJEgORRy
-
-
Mashup Score: 1
Transcatheter aortic valve replacement was safe in low-risk patients with bicuspid aortic stenosis, as shown through short hospital stays, zero disabling stroke and zero deaths at 30 days, according to data from the Low-Risk TAVR trial presented at Cardiovascular Research Technologies. “Low-risk patients with symptomatic, severe bicuspid aortic stenosis are younger than patients with
Source: www.healio.comCategories: Cardiology News and JournalsTweet-
ICYMI: TAVR was safe in low-risk patients with bicuspid aortic stenosis, as shown through short hospital stays, zero disabling stroke and zero deaths at 30 days, according to data from the Low-Risk TAVR trial presented at #CRT2020 #CRT2020 @MedStarHeart https://t.co/puItWUH7Ax
-
-
Mashup Score: 0PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE - 4 year(s) ago
The high rate of MI in the study worried some physicians, but investigators say the events have no impact on prognosis.
Source: TCTMD.comCategories: CardiologistsTweet-
"Looking at the data for periprocedural and spontaneous MI, only spontaneous MI appeared to have an impact on mortality and was identified as an independent predictor in this study." #CRT2020 @azeemlatib @GreggWStone @michaelTCTMD https://t.co/we8UDHFsdo
-
Moments from @CRTMeeting #CRT2020 👠@WomenAs1 #CardioTube discussion w Dr Spencer King on the “Global experiences of #WIC “ @AlexandraLansky @JDawnAbbott1 @DrCindyGrines https://t.co/lajv0akBXM https://t.co/NEBw9QzPks